Supplementary_Fig1.jpg (1.04 MB)
Interpatient variability in mesothelin (MSLN) expression necessitates its evaluation before gastric cancer immunotherapy. Supplementary figure
figure
posted on 2022-03-24, 08:53 authored by Mahmood Naderi, Nasim Sajadi, Bahareh Sharififard, Ramin Shakeri, Vahid Mansouri, Masoud SotoudehSupplementary Figure
1. A few representative cores showing percent positivity of MSLN in tumor cells
